213 related articles for article (PubMed ID: 33737305)
1. Predicting the safety zone for steroid-induced ocular hypertension induced by intravitreal dexamethasone implantation.
Choi W; Bae HW; Shin HJ; Kim EW; Kim CY; Kim M; Seong GJ
Br J Ophthalmol; 2022 Aug; 106(8):1150-1156. PubMed ID: 33737305
[TBL] [Abstract][Full Text] [Related]
2. Incidence, Risk Factors, Treatment, and Outcome of Ocular Hypertension following Intravitreal Steroid Injections: A Comparative Study.
Badrinarayanan L; Rishi P; George R; Isaac N; Rishi E;
Ophthalmologica; 2022; 245(5):431-438. PubMed ID: 35468616
[TBL] [Abstract][Full Text] [Related]
3. Axial Length as a Risk Factor for Steroid-Induced Ocular Hypertension.
Choi W; Kim JD; Bae HW; Kim CY; Seong GJ; Kim M
Yonsei Med J; 2022 Sep; 63(9):850-855. PubMed ID: 36031785
[TBL] [Abstract][Full Text] [Related]
4. Intraocular pressure fluctuation following intravitreal dexamethasone implant and incidence of secondary ocular hypertension: a Zambian perspective.
Raj P; Kumar K; Balasubramaniam S; Geetha CS; Agarwal A
Pan Afr Med J; 2021; 39():108. PubMed ID: 34512844
[TBL] [Abstract][Full Text] [Related]
5. [Late steroid-induced ocular hypertension after intravitreal dexamethasone implants: A series of 20 cases].
Billant J; Douma I; Agard E; Levron A; Bouvarel H; Leroux P; Badri Y; Dot C
J Fr Ophtalmol; 2023 Nov; 46(9):1039-1046. PubMed ID: 37758545
[TBL] [Abstract][Full Text] [Related]
6. Ocular hypertension following 40 mg sub-Tenon triamcinolone versus 0.7 mg dexamethasone implant versus 2 mg intravitreal triamcinolone.
Kuley B; Storey PP; Pancholy M; Bello N; Murphy J; Goodman J; Wibbelsman TD; Obeid A; Chiang A; Regillo C; Garg S
Can J Ophthalmol; 2020 Dec; 55(6):480-485. PubMed ID: 32853591
[TBL] [Abstract][Full Text] [Related]
7. Intraocular pressure change after injection of intravitreal dexamethasone (Ozurdex) implant in Korean patients.
Choi W; Park SE; Kang HG; Byeon SH; Kim SS; Koh HJ; Lee S; Seong GJ; Kim CY; Kim M
Br J Ophthalmol; 2019 Oct; 103(10):1380-1387. PubMed ID: 30523044
[TBL] [Abstract][Full Text] [Related]
8. XEN Gel Stent to Treat Intraocular Hypertension After Dexamethasone-Implant Intravitreal Injections: 5 Cases.
Rezkallah A; Mathis T; Denis P; Kodjikian L
J Glaucoma; 2019 Jan; 28(1):e5-e9. PubMed ID: 30234749
[TBL] [Abstract][Full Text] [Related]
9. Ocular Hypertension Following Intravitreal Injection of 0.7mg Dexamethasone Implant versus 2mg Triamcinolone.
Kuley B; Storey PP; Pancholy M; Obeid A; Murphy J; Goodman J; Wibbelsman TD; Regillo C; Chiang A
Semin Ophthalmol; 2020 Feb; 35(2):141-146. PubMed ID: 32343619
[No Abstract] [Full Text] [Related]
10. Baseline intraocular pressure: an independent risk factor in severe steroid-induced ocular hypertension after intravitreal dexamethasone implant.
Cho WJ; Lee JM; Bae HW; Kim CY; Seong GJ; Choi W
Graefes Arch Clin Exp Ophthalmol; 2024 Apr; 262(4):1231-1243. PubMed ID: 37930443
[TBL] [Abstract][Full Text] [Related]
11. Secondary Ocular Hypertension and the Risk of Glaucoma Surgery After Dexamethasone Intravitreal Implant in Routine Clinical Practice.
Hemarat K; Kemmer JD; Porco TC; Eaton AM; Khurana RN; Stewart JM
Ophthalmic Surg Lasers Imaging Retina; 2018 Sep; 49(9):680-685. PubMed ID: 30222802
[TBL] [Abstract][Full Text] [Related]
12. Use of selective laser trabeculoplasty as an alternative in patients who developed ocular hypertension after intravitreal dexamethasone implants: a series of 35 eyes.
Billant J; Agard E; Douma I; Levron A; Brunet O; Remignon CH; Sejournet L; Dot C
Graefes Arch Clin Exp Ophthalmol; 2022 Nov; 260(11):3665-3673. PubMed ID: 35665853
[TBL] [Abstract][Full Text] [Related]
13. Age as a risk factor for steroid-induced ocular hypertension in the non-paediatric population.
Choi W; Bae HW; Choi EY; Kim M; Kim EW; Kim CY; Kim M; Seong GJ
Br J Ophthalmol; 2020 Oct; 104(10):1423-1429. PubMed ID: 32071035
[TBL] [Abstract][Full Text] [Related]
14. Intraocular pressure monitoring post intravitreal steroids: a systematic review.
Kiddee W; Trope GE; Sheng L; Beltran-Agullo L; Smith M; Strungaru MH; Baath J; Buys YM
Surv Ophthalmol; 2013; 58(4):291-310. PubMed ID: 23768920
[TBL] [Abstract][Full Text] [Related]
15. LONG-TERM INCIDENCE AND RISK FACTORS OF OCULAR HYPERTENSION FOLLOWING DEXAMETHASONE-IMPLANT INJECTIONS: THE SAFODEX-2 STUDY.
Rezkallah A; Mathis T; Abukhashabah A; Voirin N; Malclès A; Agard É; Lereuil T; Denis P; Dot C; Kodjikian L
Retina; 2021 Jul; 41(7):1438-1445. PubMed ID: 33315814
[TBL] [Abstract][Full Text] [Related]
16. Incident glaucoma and ocular hypertension after periocular and intravitreal steroid injections: a claims-based analysis.
Polski A; Liu KC; Gupta D; Grewal DS; Horns J; Wirostko BM; Stagg BC
BMJ Open Ophthalmol; 2023 Dec; 8(1):. PubMed ID: 38135349
[TBL] [Abstract][Full Text] [Related]
17. Short-term safety of dexamethasone implant for treatment of macular edema due to retinal vein occlusion, in eyes with glaucoma or treated ocular hypertension.
Theodoropoulou S; Ellabban AA; Johnston RL; Cilliers H; Mohamed Q; Sallam AB
Graefes Arch Clin Exp Ophthalmol; 2017 Apr; 255(4):725-732. PubMed ID: 27878430
[TBL] [Abstract][Full Text] [Related]
18. OCULAR HYPERTENSION AFTER INTRAVITREAL DEXAMETHASONE (OZURDEX) SUSTAINED-RELEASE IMPLANT.
Chin EK; Almeida DRP; Velez G; Xu K; Peraire M; Corbella M; Elshatory YM; Kwon YH; Gehrs KM; Boldt HC; Sohn EH; Russell SR; Folk JC; Mahajan VB
Retina; 2017 Jul; 37(7):1345-1351. PubMed ID: 27806001
[TBL] [Abstract][Full Text] [Related]
19. DEX implant intravitreal injection, sustained intraocular hypertension, and steroid-induced glaucoma in patients with no risk factors.
Rezkallah A; Kodjikian L; Malclès A; Dot C
Graefes Arch Clin Exp Ophthalmol; 2018 Jan; 256(1):219-220. PubMed ID: 28801709
[No Abstract] [Full Text] [Related]
20. Ocular hypertension and intravitreal steroids injections, update in 2023. French guidelines of the French glaucoma society and the French ophthalmology society.
Dot C; Poli M; Aptel F; Labbe A; Kodjikian L; Baillif S; Bodaghi B; Denis P
J Fr Ophtalmol; 2023 Oct; 46(8):e249-e256. PubMed ID: 37302867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
